Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Resveratrol-based combinatorial strategies for cancer management.

Singh CK, George J, Ahmad N.

Ann N Y Acad Sci. 2013 Jul;1290:113-21. doi: 10.1111/nyas.12160. Review.

2.

Resveratrol in cancer management: where are we and where we go from here?

Ndiaye M, Kumar R, Ahmad N.

Ann N Y Acad Sci. 2011 Jan;1215:144-9. doi: 10.1111/j.1749-6632.2010.05851.x. Review.

PMID:
21261653
3.

Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).

Aziz MH, Kumar R, Ahmad N.

Int J Oncol. 2003 Jul;23(1):17-28. Review.

PMID:
12792772
4.

Resveratrol analogs: promising chemopreventive agents.

Ogas T, Kondratyuk TP, Pezzuto JM.

Ann N Y Acad Sci. 2013 Jul;1290:21-9. doi: 10.1111/nyas.12196. Review.

PMID:
23855462
5.

Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.

Mayhoub AS, Marler L, Kondratyuk TP, Park EJ, Pezzuto JM, Cushman M.

Bioorg Med Chem. 2012 Jan 1;20(1):510-20. doi: 10.1016/j.bmc.2011.09.031. Epub 2011 Sep 25.

6.

Resveratrol nanoformulation for cancer prevention and therapy.

Siddiqui IA, Sanna V, Ahmad N, Sechi M, Mukhtar H.

Ann N Y Acad Sci. 2015 Aug;1348(1):20-31. doi: 10.1111/nyas.12811. Epub 2015 Jun 24. Review.

PMID:
26109073
7.

Resveratrol in human cancer chemoprevention--choosing the 'right' dose.

Scott E, Steward WP, Gescher AJ, Brown K.

Mol Nutr Food Res. 2012 Jan;56(1):7-13. doi: 10.1002/mnfr.201100400. Epub 2011 Oct 7. Review.

PMID:
22218912
8.

Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53.

George J, Singh M, Srivastava AK, Bhui K, Roy P, Chaturvedi PK, Shukla Y.

PLoS One. 2011;6(8):e23395. doi: 10.1371/journal.pone.0023395. Epub 2011 Aug 26.

9.

A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.

Kisková T, Ekmekcioglu C, Garajová M, Orendáš P, Bojková B, Bobrov N, Jäger W, Kassayová M, Thalhammer T.

Eur J Cancer Prev. 2012 Mar;21(2):163-70. doi: 10.1097/CEJ.0b013e32834c9c0f.

PMID:
22044852
10.

Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.

Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):77-93. Review.

PMID:
12678904
11.
13.

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.

Shankar S, Singh G, Srivastava RK.

Front Biosci. 2007 Sep 1;12:4839-54. Review.

PMID:
17569614
14.

Resveratrol and derivatives for the prevention and treatment of cancer.

Fulda S.

Drug Discov Today. 2010 Sep;15(17-18):757-65. doi: 10.1016/j.drudis.2010.07.005. Epub 2010 Aug 6. Review.

PMID:
20692359
15.

Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.

Narayanan NK, Nargi D, Randolph C, Narayanan BA.

Int J Cancer. 2009 Jul 1;125(1):1-8. doi: 10.1002/ijc.24336.

16.

Resveratrol in the management of human cancer: how strong is the clinical evidence?

Gescher A, Steward WP, Brown K.

Ann N Y Acad Sci. 2013 Jul;1290:12-20. doi: 10.1111/nyas.12205. Review.

PMID:
23855461
17.

Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.

Luther DJ, Ohanyan V, Shamhart PE, Hodnichak CM, Sisakian H, Booth TD, Meszaros JG, Bishayee A.

Invest New Drugs. 2011 Apr;29(2):380-91. doi: 10.1007/s10637-009-9332-7. Epub 2009 Oct 8.

PMID:
19812893
18.

Resveratrol and cellular mechanisms of cancer prevention.

Shukla Y, Singh R.

Ann N Y Acad Sci. 2011 Jan;1215:1-8. doi: 10.1111/j.1749-6632.2010.05870.x. Review.

PMID:
21261635
19.

Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.

Kisková T, Jendželovský R, Rentsen E, Maier-Salamon A, Kokošová N, Papčová Z, Mikeš J, Orendáš P, Bojková B, Kubatka P, Svoboda M, Kajo K, Fedoročko P, Jäger W, Ekmekcioglu C, Kassayová M, Thalhammer T.

Eur J Cancer Prev. 2014 Nov;23(6):506-13. doi: 10.1097/CEJ.0000000000000083. Erratum in: Eur J Cancer Prev. 2015 Mar;24(2):165.

PMID:
25254309
20.

Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.

Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A, Britton RG, Horner-Glister E, Greaves P, Jawad D, James M, Howells L, Ognibene T, Malfatti M, Goldring C, Kitteringham N, Walsh J, Viskaduraki M, West K, Miller A, Hemingway D, Steward WP, Gescher AJ, Brown K.

Sci Transl Med. 2015 Jul 29;7(298):298ra117. doi: 10.1126/scitranslmed.aaa7619.

Supplemental Content

Support Center